GREATWALL vs Allied Biotech: monthly revenue

Monthly revenue and year-on-year change for GREATWALL (1210) and Allied Biotech (1780) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ GREATWALL ━ Allied Biotech

0%+57%-6%25/1026/0126/0426/0726/10

Monthly revenue history

MonthGREATWALLYoYAllied BiotechYoY
Oct 2026NT$9.66 billion+14.6%NT$104.4 million+29.0%
Sep 2026NT$9.88 billion+13.2%NT$88.2 million+24.1%
Aug 2026NT$9.7 billion+13.4%NT$74.8 million+12.5%
Jul 2026NT$9.64 billion+21.5%NT$82.5 million+13.8%
Jun 2026NT$8.95 billion+12.2%NT$62.7 million-6.4%
May 2026NT$9.07 billion+10.2%NT$92.2 million+57.0%
Apr 2026NT$9.1 billion+4.3%NT$103.2 million+14.7%
Mar 2026NT$9.21 billion+5.0%NT$72.8 million+28.0%
Feb 2026NT$7.63 billion-5.7%NT$93.6 million+17.8%
Jan 2026NT$9.73 billion+12.0%NT$73.9 million+0.7%
Dec 2025NT$9.59 billion+4.6%NT$66.6 million+3.1%
Nov 2025NT$8.86 billion-1.2%NT$66.4 million-4.9%
Oct 2025NT$8.43 billion-2.0%NT$81 million+56.1%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16